• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Centene Corporation (Amendment)

    2/9/23 9:59:38 AM ET
    $CNC
    Medical Specialities
    Health Care
    Get the next $CNC alert in real time by email
    SC 13G/A 1 filing.txt SCHEDULE 13G Amendment No.3 CENTENE CORP COMMON STOCK Cusip #15135B101 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #15135B101 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 25,619,507 Item 6: 0 Item 7: 29,119,901 Item 8: 0 Item 9: 29,119,901 Item 11: 5.142% Item 12: HC Cusip #15135B101 Item 1: Reporting Person - Abigail P. Johnson Item 2: (a) [ ] (b) [ ] Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 29,119,901 Item 8: 0 Item 9: 29,119,901 Item 11: 5.142% Item 12: IN Item 1(a). Name of Issuer: CENTENE CORP Item 1(b). Address of Issuer's Principal Executive Offices: 7700 Forsyth Blvd. St. Louis, MO 63105 USA Item 2(a). Name of Person Filing: FMR LLC Item 2(b). Address or Principal Business Office or, if None, Residence: 245 Summer Street, Boston, Massachusetts 02210 Item 2(c). Citizenship: Not applicable Item 2(d). Title of Class of Securities: COMMON STOCK Item 2(e). CUSIP Number: 15135B101 Item 3. This statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c) and the person filing, FMR LLC, is a parent holding company in accordance with Section 240.13d-1(b)(1)(ii)(G). (Note: See Exhibit A). Item 4. Ownership (a) Amount Beneficially Owned: 29,119,901 (b) Percent of Class: 5.142% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: Please see the responses to Items 5 and 6 on the cover page (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 29,119,901 (iv) shared power to dispose or to direct the disposition of: 0 Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of CENTENE CORP. No one other person's interest in the COMMON STOCK of CENTENE CORP is more than five percent of the total outstanding COMMON STOCK. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. See attached Exhibit A. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing orinfluencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 9, 2023 Date /s/ Stephanie J. Brown Signature Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. Exhibit A Pursuant to the instructions in Item 7 of Schedule 13G, the following table lists the identity and Item 3 classification, if applicable, of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Entity ITEM 3 Classification FIAM LLC IA Fidelity Diversifying Solutions LLC IA Fidelity Institutional Asset Management Trust Company BK Fidelity Management & Research Company LLC IA Fidelity Management Trust Company BK Strategic Advisers LLC IA Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. This filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates, and other companies (collectively, the "FMR Reporters"). This filing does not reflect securities, if any, beneficially owned by certain other companies whose beneficial ownership of securities is disaggregated from that of the FMR Reporters in accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998). RULE 13d-1(k)(1) AGREEMENT The undersigned persons, on February 9, 2023, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the COMMON STOCK of CENTENE CORP at December 30, 2022. FMR LLC By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* Abigail P. Johnson By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January, 26, 2023, by and on behalf of Abigail P. Johnson** * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.
    Get the next $CNC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CNC

    DatePrice TargetRatingAnalyst
    4/8/2025$64.00Underperform → Hold
    Jefferies
    2/6/2025Buy → Hold
    Argus
    12/17/2024$80.00 → $75.00Overweight
    Analyst
    12/13/2024$79.00 → $80.00Neutral → Buy
    UBS
    12/10/2024$68.00 → $52.00Hold → Underperform
    Jefferies
    7/24/2024$83.00 → $69.00Buy → Hold
    Jefferies
    5/30/2024$83.00Neutral
    Robert W. Baird
    3/21/2024$92.00 → $85.00Overweight → Equal-Weight
    Stephens
    More analyst ratings

    $CNC
    SEC Filings

    See more
    • Centene Corporation filed SEC Form 8-K: Regulation FD Disclosure

      8-K - CENTENE CORP (0001071739) (Filer)

      5/5/25 9:05:53 PM ET
      $CNC
      Medical Specialities
      Health Care
    • SEC Form 10-Q filed by Centene Corporation

      10-Q - CENTENE CORP (0001071739) (Filer)

      4/24/25 8:18:11 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Centene Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - CENTENE CORP (0001071739) (Filer)

      4/24/25 8:19:02 PM ET
      $CNC
      Medical Specialities
      Health Care

    $CNC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Greco Thomas bought $1,015,750 worth of shares (17,000 units at $59.75), increasing direct ownership by 736% to 19,309 units (SEC Form 4)

      4 - CENTENE CORP (0001071739) (Issuer)

      12/19/24 5:39:30 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Director Dallas H James bought $99,904 worth of shares (1,693 units at $59.01) (SEC Form 4)

      4 - CENTENE CORP (0001071739) (Issuer)

      12/17/24 7:34:06 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Director Blume Jessica L. bought $14,870 worth of shares (250 units at $59.48) (SEC Form 4)

      4 - CENTENE CORP (0001071739) (Issuer)

      12/17/24 7:33:56 PM ET
      $CNC
      Medical Specialities
      Health Care

    $CNC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • NVA Appoints Ken Burdick Executive Chairman Ahead of Future IPO

      Board further strengthened with appointment of Mike McFarland as Director National Veterinary Associates Group ("NVA"), a leading veterinary care organization, today announced it has strengthened its Board with the appointments of Ken Burdick as Executive Chairman and Dr. James "Mike" McFarland as Director. These executives bring substantial healthcare and public company experience ahead of the company's future IPO. Burdick is a seasoned public company executive with more than 40 years of healthcare experience. He currently serves as Executive Chairman at LifeStance Health (NASDAQ:LFST), a leading U.S. provider of outpatient mental healthcare. Since joining LifeStance as Chairman and CEO

      5/7/25 2:00:00 PM ET
      $CNC
      $LFST
      Medical Specialities
      Health Care
      Medical/Nursing Services
    • CENTENE SUBSIDIARY ARIZONA COMPLETE HEALTH JOINS SETTLEMENT AGREEMENT TO MOVE FORWARD WITH STATEWIDE LONG-TERM CARE MEDICAID CONTRACT

      ST. LOUIS, May 2, 2025 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that its subsidiary, Arizona Complete Health, the largest Medicaid health plan in Arizona, has joined the Arizona Health Care Cost Containment System (AHCCCS) – Arizona's single state Medicaid agency – and three other health plans in reaching a settlement agreement to provide managed care for the Arizona Long Term Care System (ALTCS). The ALTCS program supports nearly 26,000 Arizonans who are elderly and/or have a physical disability (EPD) with physical and behavioral healthcare, as well as pharmacy benefits and home- and co

      5/2/25 7:05:00 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Oklahoma Complete Health Offers New and Upgraded Benefits for SoonerSelect Members in 2025

      OKLAHOMA CITY, May 1, 2025 /PRNewswire/ -- Oklahoma Complete Health introduces new and upgraded SoonerSelect benefits to support members. Enhancements to the value-added services aim to improve health outcomes and overall well-being of members. "Oklahoma Complete Health is excited to expand the 2025 offerings to serve our members," said Oklahoma Complete Health's President and CEO Clay Franklin. "Our plan continues to prioritize the health and well-being of Oklahomans and find ways to meet their unique needs." New and upgraded benefits include: New: Diaper ClubStarting July 1,

      5/1/25 9:06:00 AM ET
      $CNC
      Medical Specialities
      Health Care

    $CNC
    Leadership Updates

    Live Leadership Updates

    See more

    $CNC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $CNC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $CNC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • NVA Appoints Ken Burdick Executive Chairman Ahead of Future IPO

      Board further strengthened with appointment of Mike McFarland as Director National Veterinary Associates Group ("NVA"), a leading veterinary care organization, today announced it has strengthened its Board with the appointments of Ken Burdick as Executive Chairman and Dr. James "Mike" McFarland as Director. These executives bring substantial healthcare and public company experience ahead of the company's future IPO. Burdick is a seasoned public company executive with more than 40 years of healthcare experience. He currently serves as Executive Chairman at LifeStance Health (NASDAQ:LFST), a leading U.S. provider of outpatient mental healthcare. Since joining LifeStance as Chairman and CEO

      5/7/25 2:00:00 PM ET
      $CNC
      $LFST
      Medical Specialities
      Health Care
      Medical/Nursing Services
    • CENTENE APPOINTS KENNETH Y. TANJI TO BOARD OF DIRECTORS

      ST. LOUIS, Feb. 24, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today the appointment of Kenneth Y. Tanji to the Centene Board of Directors, effective February 20, 2025. Mr. Tanji will serve on the Company's Audit and Compliance Committee. The appointment of Mr. Tanji expands Centene's Board of Directors to 12 members. Mr. Tanji's finance acumen spans more than three decades and includes deep knowledge of capital optimization strategies, strategic acquisitions, JV partnership models and the use of advanced analytics and technologies to scale g

      2/24/25 4:15:00 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Centene Corporation Names First President over Individual Coverage Health Reimbursement Arrangements (ICHRA) Business

      New leadership role reflects Centene's focus on ICHRA growth ST LOUIS, Jan. 9, 2025 /PRNewswire/ -- Centene Corporation ("Centene") (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, is pleased to announce that Alan Silver has joined the organization as the President of its Ambetter Health Solutions business, which focuses on ICHRA (Individual Coverage Health Reimbursement Arrangements). This newly created role reflects Centene's belief that consumers increasingly will seek health insurance that offers transparency, customization, choice and convenience. ICHRA plans allow employees to shop on the individual Marketplace and choose the insurance plan

      1/9/25 9:00:00 AM ET
      $CNC
      Medical Specialities
      Health Care
    • Chief Financial Officer Asher Andrew Lynn covered exercise/tax liability with 10,566 shares, decreasing direct ownership by 2% to 657,642 units (SEC Form 4)

      4 - CENTENE CORP (0001071739) (Issuer)

      4/28/25 6:32:31 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Corporate Controller & CAO Casso Katie covered exercise/tax liability with 2,077 shares, decreasing direct ownership by 2% to 96,335 units (SEC Form 4)

      4 - CENTENE CORP (0001071739) (Issuer)

      4/21/25 5:50:08 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Chief People Officer Mcnally Tanya M covered exercise/tax liability with 964 shares, decreasing direct ownership by 2% to 59,494 units (SEC Form 4)

      4 - CENTENE CORP (0001071739) (Issuer)

      4/16/25 4:43:24 PM ET
      $CNC
      Medical Specialities
      Health Care
    • SEC Form SC 13G filed by Centene Corporation

      SC 13G - CENTENE CORP (0001071739) (Subject)

      11/14/24 4:06:01 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Centene Corporation

      SC 13G/A - CENTENE CORP (0001071739) (Subject)

      11/13/24 3:02:23 PM ET
      $CNC
      Medical Specialities
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Centene Corporation

      SC 13G/A - CENTENE CORP (0001071739) (Subject)

      11/12/24 9:55:15 AM ET
      $CNC
      Medical Specialities
      Health Care
    • Centene upgraded by Jefferies with a new price target

      Jefferies upgraded Centene from Underperform to Hold and set a new price target of $64.00

      4/8/25 9:08:11 AM ET
      $CNC
      Medical Specialities
      Health Care
    • Centene downgraded by Argus

      Argus downgraded Centene from Buy to Hold

      2/6/25 7:52:15 AM ET
      $CNC
      Medical Specialities
      Health Care
    • Analyst resumed coverage on Centene with a new price target

      Analyst resumed coverage of Centene with a rating of Overweight and set a new price target of $75.00 from $80.00 previously

      12/17/24 7:34:22 AM ET
      $CNC
      Medical Specialities
      Health Care

    $CNC
    Financials

    Live finance-specific insights

    See more
    • CENTENE CORPORATION REPORTS FIRST QUARTER 2025 RESULTS

      -- Diluted EPS of $2.63; Adjusted Diluted EPS of $2.90 -- First quarter 2025 adjusted diluted EPS of $2.90, up 28% from $2.26 in the first quarter of 2024.17% year-over-year premium and service revenue growth.Membership increases of 29% in Marketplace and 22% in Medicare PDP, compared to the first quarter of 2024.Increased 2025 premium and service revenues guidance by $6.0 billion driven by outperformance in Marketplace enrollment and Medicare member retention.ST. LOUIS, April 25, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) (the Company) announced today its financial results for the first quarter ended March 31, 2025. In summary, the 2025 first quarter results were as follows: Total

      4/25/25 6:00:00 AM ET
      $CNC
      Medical Specialities
      Health Care
    • CENTENE CORPORATION TO HOST 2025 FIRST QUARTER FINANCIAL RESULTS EARNINGS CALL

      ST. LOUIS, March 18, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it will release its 2025 first quarter financial results at approximately 6:00 a.m. ET on Friday, April 25, 2025, and host a conference call at 8:30 a.m. ET to review the results. Investors and other interested parties are invited to listen to the conference call by dialing 1-877-883-0383 in the U.S. and Canada; +1-412-902-6506 from abroad, including the following Elite Entry Number: 9776439 to expedite caller registration; or via a live, audio webcast on the Company's website at www.centene.com, under the Investors

      3/18/25 4:53:00 PM ET
      $CNC
      Medical Specialities
      Health Care
    • CENTENE CORPORATION REPORTS 2024 RESULTS

      -- 2024 Full Year Diluted EPS of $6.31; Adjusted Diluted EPS of $7.17 -- 2024 adjusted diluted EPS of $7.17, up 7% from $6.68 in 2023.Membership increases of 12% in Marketplace and 50% in Medicare PDP, compared to the fourth quarter of 2023.Executed on capital deployment with $3.0 billion of share repurchases in 2024.Increased 2025 premium and service revenues guidance by $4.0 billion driven by Medicaid revenue and better than expected membership performance during the annual enrollment period in Medicare Advantage and PDP.ST. LOUIS, Feb. 4, 2025 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today its financial results for the fourth quarter and year ended December

      2/4/25 6:00:00 AM ET
      $CNC
      Medical Specialities
      Health Care